Specialty Pharmacy

Researchers believe drug will lead to ‘new paradigm' in leukemia therapy.

Moderate to intense exercise carries wide range of benefits.

Scalp cooling technology seeks to ensure hair retention in most instances.

Blood test may identify patients who need more intensive chemotherapy.

Addition of long-term care pharmacies strengthens service of eastern North Carolina and southwest Florida.

Current smokers and those who quit less than 10 years prior to surgery face twice the risk of disease recurrence.

Genetic changes in tumors linked to immune system response to disease.

The pharmacist's role as a disease educator is moving to the forefront.

A pharmacist in Cleveland, Tennessee, has surrendered her license following an investigation into her compounding pharmacy's use of potentially unsafe ingredients.

Commonly cited estimates on how easily newly infected patients transmit HIV may be vastly overstated.

States that expanded Medicaid coverage under the Affordable Care Act have seen a 23% increase in the number of newly diagnosed diabetes patients.

Formic acid from stinging nettles and ants greatly increases treatment's ability to shut down cancer cells.

Errors in genes may leave tumors susceptible to PARP inhibitors.

Cancer drug prices have increased 10% each year since 1995, even after adjusting for inflation and incremental health benefits.

Treatment increases immune response with fewer side effects.

Nanoscale treatment could potentially eliminate cancer cells without harming surrounding tissue.

Co-administration of amiodarone and Sovaldi or Harvoni also causes 9 patients to develop abnormally slow heartbeats, 3 requiring pacemakers.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses adherence trends specialty pharmacies need to be aware of.

Procedure allows acute liver failure patients to receive a transplant before their condition worsens.

Emerging technology could help patients make better decisions regarding whether to undergo aggressive prostate cancer treatment.

A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.

Communication helps pharmacists better assess difficulties patients encounter during treatment.

A health-system pharmacist was recently let go after peeking at the health records of patients not in his care.

Condition shares pathogenic mechanisms with rheumatoid arthritis.

Acquisition creates most integrated pharmacy technology company in the industry.

Over approximately 1 year, evolocumab reduces cholesterol levels by 61% and reduces cardiovascular event rates by 53% in patients with hyperlipidemia when used in conjunction with standard therapies.

Significant number of patients taking once daily oral therapy achieve clinical remission during a recent trial.

Discovery may lead to new treatment designs.